News & Updates

Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.

Never smokers with selected risk factors who undergo lung cancer screening may show similar detection rates to high-risk ever smokers or even higher rates when compared with unselected never smokers, reveals a Singapore study.